Brief: Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
10/02/2025 13:08
Feb 10 (Reuters) - Ocean Biomedical OCEA.O :
* OCEAN BIOMEDICAL ANNOUNCES BREAKTHROUGH FINDINGS IN
EGFR-MUTANT
LUNG CANCER AND PLANS FOR FDA ALIGNMENT ON NEXT-STAGE
DEVELOPMENT
* OCEAN BIOMEDICAL- TO INITIATE PRECLINICAL STUDIES TO
ADVANCE
IMMUNOTHERAPY PROGRAM & TO ENGAGE WITH FDA FOR FIRST-IN-HUMAN
TRIALS
Source text: ID:nGNX9fMqJF
Further company coverage: OCEA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocean Biomedical
See all newsTrump's shipbuilding plan could upend ocean cargo industry, companies warn
Brief: Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Ocean Biomedical receives Nasdaq staff determination letter
Brief: Ocean Biomedical- Ratified Fully Countersigned Copy Of Revised Agreement With Virion Therapeutics Received On Sept 26